A new research study combining marine physiology, neuroscience, pharmacology, and behavioral psychology has revealed a surprising outcome from increases of carbon dioxide uptake in the oceans: anxious fish.
Expanding their efforts to keep citizens safe on San Diego roadways, UC San Diego’s Training, Research and Education for Driving Safety (TREDS) program announced today that they are launching a new distracted driving education project called Just Drive - Take Action Against Distraction, a one hour class free of charge offered to businesses in San Diego.
In the first global assessment of its kind, a science team led by researchers at Scripps Institution of Oceanography at UC San Diego has produced a landmark report on the impact of fishing on a group of fish known to protect the health of coral reefs. The report, published in the journal Proceedings of the Royal Society B (Biological Sciences), offers key data for setting management and conservation targets to protect and preserve fragile coral reefs.
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This “nanosponge vaccine” enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA—both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
Using quantitative models of bacterial growth, a team of UC San Diego biophysicists has discovered the bizarre way by which antibiotic resistance allows bacteria to multiply in the presence of antibiotics, a growing health problem in hospitals and nursing homes across the United States.
Using advanced methodologies that pit drug compounds against specific types of malaria parasite cells, an international team of scientists, including researchers at the University of California, San Diego School of Medicine and the Genomics Institute of the Novartis Research Foundation, have identified a potential new weapon and approach for attacking the parasites that cause malaria.